Media Newsroom of
National Tay-Sachs & Allied Diseases
The nation's first rare disease advocacy organization, NTSAD, founded in 1957, funds research toward treatments for Tay-Sachs and related genetic neurodegenerative diseases, supports affected families worldwide and educates on disease prevention.
As Gene Therapy Trial Commences, National Tay-Sachs & Allied Diseases Association Announces New Board Members
National Tay-Sachs & Allied Diseases Association (NTSAD), a leading advocacy group serving those impacted by Tay-Sachs, Canavan, Sandhoff and Gangliosidosis-1 (GM-1) worldwide, announced the appointment of four new members to its board of directors. Gerry Cox, M.D., Ph.D., Jason Duncan, Jamie Ring and Carla Steckman…